Literature DB >> 15217087

Heme oxygenase in experimental intracerebral hemorrhage: the benefit of tin-mesoporphyrin.

Arnulf H Koeppen1, Andrew C Dickson, Joanne Smith.   

Abstract

The prognosis of intracerebral hemorrhage (ICH) is unfavorable. Beyond immediate mass effect and tissue destruction, ICHs cause additional neuronal loss in a "perifocal reactive zone." Heme in ICH induces heme oxygenase-1 (HO-1), and the action of this enzyme on heme yields ferrous iron, biliverdin, and carbon monoxide. Iron is ultimately converted to ferritin and hemosiderin. Free iron is tissue-toxic, and inhibition of HO-1 should provide protection against additional damage. Experimental ICHs were made in adult rabbits by the stereotaxic injection of autologous blood, and the induction of HO-1 and increase in ferritin were followed by confocal immunofluorescence microscopy. Heme diffused rapidly through perivascular spaces, and HO-1 reaction product first occurred in perivascular cells and microglia. At this stage, HO-1 and ferritin showed extensive colocalization. As ICH resolution progressed, HO-1 immunoreactivity faded while ferritin and hemosiderin continued to accumulate. This process was accompanied by a gradient of destruction of neuronal cell bodies and dendrites in the perifocal reactive zone. In an effort to inhibit HO-1, repeated intravenous injections of tin-mesoporphyrin IX (SnMP) were given to ICH-bearing rabbits. The ICH disrupted the blood-brain barrier sufficiently to allow SnMP to enter the brain in pharmacological amounts, and the metalloporphyrin provided significant protection against neuronal loss.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15217087     DOI: 10.1093/jnen/63.6.587

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  39 in total

1.  Iron accumulation and neurotoxicity in cortical cultures treated with holotransferrin.

Authors:  Jing Chen-Roetling; Wenpei Liu; Raymond F Regan
Journal:  Free Radic Biol Med       Date:  2011-08-30       Impact factor: 7.376

2.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

3.  Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage.

Authors:  Jian Wang; Sylvain Doré
Journal:  Brain       Date:  2007-06       Impact factor: 13.501

4.  Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury.

Authors:  Luna Benvenisti-Zarom; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2007-03-24       Impact factor: 5.996

5.  Heme oxygenase activity and hemoglobin neurotoxicity are attenuated by inhibitors of the MEK/ERK pathway.

Authors:  Jing Chen-Roetling; Zhi Li; Mai Chen; Olatilewa O Awe; Raymond F Regan
Journal:  Neuropharmacology       Date:  2009-02-06       Impact factor: 5.250

6.  Hemoglobin neurotoxicity is attenuated by inhibitors of the protein kinase CK2 independent of heme oxygenase activity.

Authors:  Jing Chen-Roetling; Zhi Li; Raymond F Regan
Journal:  Curr Neurovasc Res       Date:  2008-08       Impact factor: 1.990

7.  Iron localization in superficial siderosis of the central nervous system.

Authors:  Harry Kellermier; Guoji Wang; Clayton Wiley
Journal:  Neuropathology       Date:  2008-08-07       Impact factor: 1.906

8.  Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage.

Authors:  Xiangping Lu; Jing Chen-Roetling; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2014-06-18       Impact factor: 5.996

9.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

10.  Increasing expression of H- or L-ferritin protects cortical astrocytes from hemin toxicity.

Authors:  Zhi Li; Jing Chen-Roetling; Raymond F Regan
Journal:  Free Radic Res       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.